[Regulation]Regulation update: Partial Amendment to the Designation of Priority Control Substances under K-REACH (July 2025)

6 Aug 2025

In accordance with the designation of Priority Control Substances notified on July 21, 2025 (Ministry of Environment Notification No. 2025-125), the list of Priority Control Substances has been partially amended.

 

Regulation Overview

  • K-REACH is a regulatory framework that aims to protect human health and the environment by requiring the registration, evaluation, and control of chemical substances manufactured, imported, or used in Korea.

  • Priority Control Substances refer to chemical substances that are of concern due to potential risks, as defined in Article 2 (10-2) of K-REACH and Article 3-2 of its Enforcement Decree.

  • These substances are designated and publicly notified in order to mandate prior notification before the manufacture or import of products containing them.

  • A “product” refers to an article, its component, or accessory used by consumers that may potentially expose the user to chemical substances. The following types are included:

    • Products composed of mixtures

    • Products in solid form that perform specific functions and do not release chemical substances during use


Key amendment details

  • Revised the names and remarks of chemical substances listed in the current annex.

    • Aligned chemical substance names with those used for existing chemicals.

    •  Reflected amendments to Annex 1-2 (Criteria for Notification of Priority Control Substances) of the Enforcement Decree of K-REACH.

    • Added “respiratory sensitization” to the remarks section.

  • Entry into force: August 7, 2025

  • Priority Control Substances:


MDSKorea Inc. 

Head Office: 314, Gwanggyojungang-ro, Suji-gu, Yongin-si, Gyeonggi-do, Korea

Seoul Office 1: 173, Digital-ro, Geumcheon-gu, Seoul, Korea

Seoul Office 2: 61, Namhyeon 3-gil, Gwanak-gu, Seoul, Korea

Copyright ⓒ 2023 MDSKorea Inc. All Rights Reserved

Business Registration No.: 142-81-81626 | E-commerce Registration No.: 2024-YonginSuji-1885 

Representative: Yongyeon Hwang


Request a Consultation

Have questions about our services? 

Submit your inquiry, and our team will get back to you promptly.

MDSKorea Inc.

  Head Office

314, Gwanggyojungang-ro, Suji-gu, Yongin-si, Gyeonggi-do, Korea

  Seoul Office

173, Digital-ro, Geumcheon-gu, Seoul, Korea 

  Incheon Office

22, Inha-ro 489beon-gil, Namdong-gu, Incheon, Korea 

ⓒ 2023 MDSKorea Inc. All Rights Reserved